Bruce Booth, Director, Ten Percent Owner at Larimar Therapeutics, holds 675.34K shares in Kymera Therapeutics (Ticker: KYMR), holds 3.00M shares in Sionna Therapeutics, Inc. (Ticker: SION), holds 0.00 shares in Vigil Neuroscience Inc (Ticker: VIGL).
Bruce Booth latest transaction was an Uninformative Sell of $7.38M.
What was Bruce Booth's most profitable transaction?
Bruce Booth’s most profitable transaction was an Informative Buy of SION stock on February 10, 2025. The return on the trade was 70.90%.
What is Bruce Booth's role in Larimar Therapeutics?
Bruce Booth's role in Larimar Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.